| Manual for the extrapyramidal symptom rating scale (ESRS) G Chouinard, HC Margolese Schizophrenia research 76 (2-3), 247-265, 2005 | 447 | 2005 |
| Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences HC Margolese, L Malchy, JC Negrete, R Tempier, K Gill Schizophrenia research 67 (2-3), 157-166, 2004 | 391 | 2004 |
| Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction HC Margolese, G Chouinard, TT Kolivakis, L Beauclair, R Miller The Canadian Journal of Psychiatry 50 (9), 541-547, 2005 | 187 | 2005 |
| Risk factors for completed suicide in schizophrenia and other chronic psychotic disorders: A case–control study A McGirr, M Tousignant, D Routhier, L Pouliot, N Chawky, HC Margolese, ... Schizophrenia Research 84 (1), 132-143, 2006 | 168 | 2006 |
| Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia HC Margolese, G Chouinard, TT Kolivakis, L Beauclair, R Miller, ... The Canadian Journal of Psychiatry 50 (11), 703-714, 2005 | 159 | 2005 |
| Remission in schizophrenia: critical and systematic review B AlAqeel, HC Margolese Harvard Review of Psychiatry 20 (6), 281-297, 2012 | 151 | 2012 |
| A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia NH Bhanji, G Chouinard, HC Margolese European Neuropsychopharmacology 14 (2), 87-92, 2004 | 137 | 2004 |
| High incidence of thyroiditis and anti-thyroid autoantibodies in NOD mice NF Bernard, F Ertug, H Margolese Diabetes 41 (1), 40-46, 1992 | 137 | 1992 |
| Switching from brand‐name to generic psychotropic medications: A literature review JE Desmarais, L Beauclair, HC Margolese CNS neuroscience & therapeutics 17 (6), 750-760, 2011 | 124 | 2011 |
| Engaging in psychotherapy with the Orthodox Jew: A critical review HC Margolese American Journal of Psychotherapy 52 (1), 37-53, 1998 | 117 | 1998 |
| A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use HC Margolese, JC Negrete, R Tempier, K Gill Schizophrenia research 83 (1), 65-75, 2006 | 101 | 2006 |
| Comparing three‐year extension of early intervention service to regular care following two years of early intervention service in first‐episode psychosis: a randomized single … A Malla, R Joober, S Iyer, R Norman, N Schmitz, T Brown, D Lutgens, ... World Psychiatry 16 (3), 278-286, 2017 | 85 | 2017 |
| The male menopause and mood: testosterone decline and depression in the aging male—is there a link? HC Margolese Journal of geriatric psychiatry and neurology 13 (2), 93-101, 2000 | 85 | 2000 |
| Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment? JE Desmarais, L Beauclair, HC Margolese Journal of psychopharmacology 26 (9), 1167-1174, 2012 | 82 | 2012 |
| Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder HC Margolese, G Chouinard, L Beauclair, MC Bélanger Journal of clinical psychopharmacology 22 (4), 347-352, 2002 | 78 | 2002 |
| Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia. E Levy, HC Margolese, G Chouinard | 78 | 2002 |
| Sexual side effects of antidepressants: a review HC Margolese, P Assalian Journal of Sex & Marital Therapy 22 (3), 209-217, 1996 | 71 | 1996 |
| Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia JE Desmarais, L Beauclair, L Annable, MC Bélanger, TT Kolivakis, ... Therapeutic advances in psychopharmacology 4 (6), 257-267, 2014 | 59 | 2014 |
| Olanzapine-induced somnambulism TT Kolivakis, HC Margolese, L Beauclair, G Chouinard American Journal of Psychiatry 158 (7), 1158-1158, 2001 | 55 | 2001 |
| The best predictor of the future—the metaverse, mental health, and lessons learned from current technologies D Benrimoh, FD Chheda, HC Margolese JMIR Mental Health 9 (10), e40410, 2022 | 52 | 2022 |
